Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
| Date | Insider | Title | Type | Price | Shares | Value | Owned After |
|---|---|---|---|---|---|---|---|
| Jul 1, 26 | Black Robe Capital LLC | 10 percent owner | Sale | -- | 3.20M | -- | 19.90M |
| May 4, 26 | OSMAN RONALD E | CTO | Purchase | -- | 50.00K | -- | 23.61M |
| May 4, 26 | Yanez Michelle | CTO | Purchase | -- | 50.00K | -- | 1.22M |
| May 4, 26 | SEARS SAMUEL P JR | CTO | Purchase | -- | 50.00K | -- | 1.23M |
| May 4, 26 | ODONNELL FRANCIS E JR | CEO | Purchase | -- | 50.00K | -- | 150.00K |
| May 4, 26 | Jerman Michael Allen | CTO | Purchase | -- | 50.00K | -- | 180.41K |
| May 5, 26 | Vasisht Niraj | CTO | Purchase | -- | 50.00K | -- | 200.00K |
| Apr 1, 25 | Vasisht Niraj | CTO | Purchase | -- | 50.00K | -- | -- |
| Apr 1, 25 | Yanez Michelle | CTO | Purchase | -- | 50.00K | -- | 896.27K |
| Apr 1, 25 | SEARS SAMUEL P JR | CTO | Purchase | -- | 50.00K | -- | 1.28M |
| Apr 1, 25 | OSMAN RONALD E | CTO | Purchase | -- | 50.00K | -- | 23.55M |
| Apr 1, 25 | Jerman Michael Allen | CTO | Purchase | -- | 50.00K | -- | 80.41K |
| Dec 2, 24 | MCNULTY JAMES A | CFO | Purchase | -- | 1.00M | -- | 1.95M |
| Dec 31, 24 | MCNULTY JAMES A | Officer | Sale | -- | -- | -- | -- |
| Dec 2, 24 | Yanez Michelle | CTO | Purchase | -- | 250.00K | -- | 1.15M |
| Dec 31, 24 | Yanez Michelle | CTO | Sale | -- | -- | -- | -- |
| Apr 1, 24 | Yanez Michelle | CTO | Purchase | -- | 50.00K | -- | 896.27K |
| Mar 16, 24 | MCNULTY JAMES A | CFO | Purchase | $0.08 | 100.00K | $8.00K | 100.00K |
| Apr 1, 24 | SEARS SAMUEL P JR | CTO | Purchase | -- | 50.00K | -- | 1.13M |
| Apr 1, 24 | OSMAN RONALD E | CTO | Purchase | -- | 50.00K | -- | 23.56M |
| Apr 1, 24 | Jerman Michael Allen | CTO | Purchase | -- | 50.00K | -- | 80.41K |
| Aug 11, 23 | OSMAN RONALD E | CTO | Purchase | -- | 25.00K | -- | 23.51M |
| May 5, 23 | Ronald E Osman Irrevocable Trust III | 10 percent owner | Sale | -- | -- | -- | 23.49M |
| May 5, 23 | TPB 2012 LLC | 10 percent owner | Sale | -- | -- | -- | 27.92M |
| May 5, 23 | TPB 2012 LLC | 10 percent owner | Sale | -- | -- | -- | 349.50K |
| May 5, 23 | MCNULTY JAMES A | Officer | Purchase | -- | 20.10M | -- | 26.10M |
| May 5, 23 | MCNULTY JAMES A | Officer | Purchase | -- | 398.13K | -- | 946.13K |
| May 5, 23 | MCNULTY JAMES A | Officer | Sale | -- | 79.63M | -- | -- |
| May 5, 23 | Black Robe Capital LLC | 10 percent owner | Sale | -- | -- | -- | 20.10M |
| May 5, 23 | Yanez Michelle | CTO | Purchase | -- | 796.27K | -- | 800.67K |
| Dec 13, 22 | SEARS SAMUEL P JR | CTO | Sale | -- | -- | -- | 969.10K |
| Dec 13, 22 | Vasisht Niraj | -- | Sale | -- | -- | -- | -- |
| Dec 13, 22 | Vasisht Niraj | CTO | Sale | -- | -- | -- | -- |
| Dec 13, 22 | Yanez Michelle | CTO | Sale | -- | -- | -- | 4.40K |
| Dec 13, 22 | ODONNELL FRANCIS E JR | Officer | Sale | -- | -- | -- | 85.63M |
| Jul 1, 16 | MCNULTY JAMES A | Officer | Sale | $0.24 | 150.00K | $36.00K | -- |
| Dec 13, 22 | MCNULTY JAMES A | Officer | Sale | -- | -- | -- | 85.63M |
| Dec 13, 22 | MCNULTY JAMES A | Officer | Sale | -- | -- | -- | 548.00K |
| Jan 15, 21 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | -- | 2.24M | -- | 204.08M |
| Dec 22, 20 | Hasara Garrison J. | CFO | Purchase | $0.03 | 125.00K | $3.88K | 125.00K |
| Dec 22, 20 | Watson W. Mark | CTO | Purchase | $0.03 | 1.31M | $40.50K | 1.31M |
| Dec 22, 20 | Ono Richard Dana | CTO | Purchase | $0.03 | 754.84K | $23.40K | 754.84K |
| Dec 22, 20 | Peattie Debra | CTO | Purchase | $0.03 | 580.65K | $18.00K | 580.65K |
| Dec 22, 20 | VIRCA NICHOLAS J | CEO | Purchase | $0.03 | 125.00K | $3.88K | 125.00K |
| Dec 22, 20 | Martin Robert Daniel | CTO | Purchase | $0.03 | 754.84K | $23.40K | 754.84K |
| Sep 17, 20 | VIRCA NICHOLAS J | CEO | Purchase | $0.05 | 100.00K | $5.40K | 100.00K |
| Sep 17, 20 | Hasara Garrison J. | CFO | Purchase | $0.05 | 100.00K | $5.40K | 100.00K |
| Jul 15, 20 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | -- | 3.19M | -- | 201.84M |
| Mar 20, 20 | Ono Richard Dana | CTO | Purchase | $0.05 | 1.00M | $50.00K | 1.00M |
| Mar 20, 20 | Peattie Debra | CTO | Purchase | $0.05 | 1.00M | $50.00K | 1.00M |
| Mar 20, 20 | Martin Robert Daniel | CTO | Purchase | $0.05 | 1.00M | $50.00K | 1.00M |
| Mar 20, 20 | Watson W. Mark | CTO | Purchase | $0.05 | 1.50M | $75.00K | 1.50M |
| Dec 12, 19 | Watson W. Mark | CTO | Purchase | $0.06 | 500 | $30.95 | 1.05M |
| Dec 31, 19 | Watson W. Mark | CTO | Sale | -- | -- | -- | -- |
| Dec 12, 19 | Peattie Debra | CTO | Purchase | $0.05 | 210.00K | $10.50K | 210.00K |
| Dec 2, 19 | Hasara Garrison J. | CFO | Purchase | $0.07 | 13.50K | $945 | 3.97M |
| Oct 30, 19 | Peattie Debra | CTO | Sale | -- | -- | -- | -- |
| Jun 3, 19 | Watson W. Mark | CTO | Purchase | $0.07 | 25.00K | $1.82K | 25.00K |
| Feb 3, 19 | Ono Richard Dana | CTO | Purchase | $0.08 | 657.89K | $50.00K | 657.89K |
| Feb 3, 19 | Martin Robert Daniel | CTO | Purchase | $0.08 | 657.89K | $50.00K | 657.89K |
| Feb 3, 19 | Watson W. Mark | CTO | Purchase | $0.08 | 657.89K | $50.00K | 657.89K |
| Feb 3, 19 | MAGRAB E. BRENDAN | CTO | Purchase | $0.08 | 986.84K | $75.00K | 986.84K |
| Jan 15, 19 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | -- | 362.12K | -- | 198.65M |
| Dec 20, 18 | Martin Robert Daniel | CTO | Purchase | $0.08 | 60.00K | $4.80K | 116.00K |
| Dec 20, 18 | MAGRAB E. BRENDAN | CTO | Purchase | $0.08 | 65.00K | $5.20K | 65.00K |
| Jul 15, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | -- | 184.80K | -- | 198.29M |
| Aug 30, 18 | Hasara Garrison J. | CFO | Sale | $0.27 | 100.00K | $27.00K | 3.96M |
| Jul 5, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | -- | 2.32M | -- | 5.80M |
| Jul 5, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $0.28 | 1.74M | $478.26K | 1.74M |
| Jul 5, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $0.23 | 1.74M | $400.00K | 1.74M |
| Mar 13, 18 | Martin Robert Daniel | CTO | Purchase | $0.27 | 253.00K | $68.87K | 253.00K |
| Mar 13, 18 | Martin Robert Daniel | CTO | Purchase | $0.27 | 56.00K | $15.24K | 56.00K |
| Mar 13, 18 | MAGRAB E. BRENDAN | CTO | Purchase | $0.27 | 345.00K | $93.91K | 345.00K |
| Mar 13, 18 | Ono Richard Dana | CTO | Purchase | $0.27 | 253.00K | $68.87K | 253.00K |
| Mar 13, 18 | Ono Richard Dana | CTO | Purchase | $0.27 | 56.00K | $15.24K | 56.00K |
| Mar 13, 18 | Watson W. Mark | CTO | Purchase | $0.27 | 253.00K | $68.87K | 253.00K |
| Mar 13, 18 | Watson W. Mark | CTO | Purchase | $0.27 | 76.00K | $20.69K | 76.00K |
| Mar 13, 18 | Hasara Garrison J. | CFO | Purchase | $0.27 | 260.00K | $70.77K | 260.00K |
| Mar 13, 18 | VIRCA NICHOLAS J | CEO | Purchase | $0.27 | 310.00K | $84.38K | 310.00K |
| Dec 19, 17 | Cross Stefan | CTO | Sale | $162,660.00 | 600.00K | $97.60B | -- |
| Dec 19, 17 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $162,660.00 | 600.00K | $97.60B | 198.11M |
| Jan 10, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | -- | 3.48M | -- | 3.48M |
| Jan 10, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $0.28 | 2.61M | $717.39K | 2.61M |
| Jan 10, 18 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $0.23 | 2.61M | $600.00K | 2.61M |
| May 4, 17 | Martin Robert Daniel | CTO | Purchase | -- | 60.00K | -- | 60.00K |
| May 4, 17 | MAGRAB E. BRENDAN | CTO | Purchase | -- | 65.00K | -- | 65.00K |
| Jun 30, 17 | HedgePath, LLC | 10 percent owner | Sale | $500,000.00 | 2.50M | $1.25T | 79.63M |
| Mar 8, 17 | Watson W. Mark | CTO | Purchase | -- | 200.00K | -- | 632.80K |
| Mar 8, 17 | Watson W. Mark | CTO | Purchase | -- | 400.00K | -- | 591.20K |
| Mar 8, 17 | Watson W. Mark | CTO | Sale | $0.34 | 79.20K | $26.93K | 553.60K |
| Mar 8, 17 | Watson W. Mark | CTO | Sale | $0.34 | 158.40K | $53.86K | 432.80K |
| Mar 8, 17 | Watson W. Mark | CTO | Purchase | -- | 300.00K | -- | 310.00K |
| Mar 8, 17 | Watson W. Mark | CTO | Sale | $0.34 | 118.80K | $40.39K | 191.20K |
| Mar 8, 17 | Watson W. Mark | CTO | Sale | -- | 200.00K | -- | -- |
| Mar 8, 17 | Hasara Garrison J. | CFO | Purchase | -- | 3.50M | -- | 5.53M |
| Mar 8, 17 | Hasara Garrison J. | CFO | Sale | $0.34 | 1.47M | $499.96K | 4.06M |
| Mar 8, 17 | Hasara Garrison J. | CFO | Purchase | -- | 3.50M | -- | 3.50M |
| Mar 8, 17 | Hasara Garrison J. | CFO | Sale | $0.34 | 1.47M | $499.96K | 2.03M |
| Mar 8, 17 | Hasara Garrison J. | CFO | Sale | -- | 3.50M | -- | -- |
| Mar 8, 17 | VIRCA NICHOLAS J | CEO | Purchase | -- | 15.04M | -- | 15.04M |
| Mar 8, 17 | VIRCA NICHOLAS J | CEO | Sale | $0.34 | 6.31M | $2.15M | 8.73M |
| Mar 8, 17 | VIRCA NICHOLAS J | CEO | Sale | -- | 15.04M | -- | -- |
| Mar 8, 17 | Cross Stefan | CTO | Purchase | -- | 300.00K | -- | 600.00K |
| Mar 8, 17 | Cross Stefan | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Mar 8, 17 | Cross Stefan | CTO | Sale | -- | 300.00K | -- | -- |
| Mar 8, 17 | Ono Richard Dana | CTO | Purchase | -- | 150.00K | -- | 512.40K |
| Mar 8, 17 | Ono Richard Dana | CTO | Purchase | -- | 300.00K | -- | 481.20K |
| Mar 8, 17 | Ono Richard Dana | CTO | Sale | $0.34 | 59.40K | $20.20K | 453.00K |
| Mar 8, 17 | Ono Richard Dana | CTO | Sale | $0.34 | 118.80K | $40.39K | 362.40K |
| Mar 8, 17 | Ono Richard Dana | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Mar 8, 17 | Ono Richard Dana | CTO | Sale | $0.34 | 118.80K | $40.39K | 181.20K |
| Mar 8, 17 | Ono Richard Dana | CTO | Sale | -- | 150.00K | -- | -- |
| Nov 30, 16 | Martin Robert Daniel | CTO | Sale | -- | -- | -- | -- |
| Nov 22, 16 | MAGRAB E. BRENDAN | CTO | Sale | -- | -- | -- | -- |
| Nov 15, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $583,200.00 | 4.86M | $2.83T | 197.51M |
| Nov 15, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $24.98 | 333 | $8.32K | 192.65M |
| Nov 15, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $417,099.96 | 4.75M | $1.98T | 192.65M |
| Nov 15, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Sale | $0.12 | 4.86M | $583.20K | 23.50M |
| Nov 15, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Sale | $0.08 | 333 | $24.975 | -- |
| Nov 15, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Sale | $0.09 | 4.75M | $417.10K | -- |
| Nov 4, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $2,499,975.00 | 33.33M | $83.33T | 187.90M |
| Nov 4, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Purchase | $482,900.00 | 5.50M | $2.66T | 154.56M |
| Nov 4, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Sale | $0.09 | 5.50M | $482.90K | 4.75M |
| Nov 4, 16 | Mayne Pharma Ventures Pty Ltd | 10 percent owner | Sale | $0.08 | 33.33M | $2.50M | 333 |
| Jul 1, 16 | Watson W. Mark | CTO | Purchase | -- | 200.00K | -- | 200.00K |
| Jul 1, 16 | Watson W. Mark | CTO | Purchase | $0.24 | 200.00K | $48.00K | 200.00K |
| Jul 1, 16 | SEARS SAMUEL P JR | CTO | Purchase | $0.24 | 150.00K | $36.00K | 150.00K |
| Jul 1, 16 | SEARS SAMUEL P JR | CTO | Purchase | -- | 150.00K | -- | 150.00K |
| Jul 1, 16 | Ono Richard Dana | CTO | Purchase | -- | 150.00K | -- | 150.00K |
| Jul 1, 16 | Ono Richard Dana | CTO | Purchase | $0.24 | 150.00K | $36.00K | 150.00K |
| Jun 15, 16 | HedgePath, LLC | 10 percent owner | Sale | $192,000.00 | 2.56M | $491.52B | 82.13M |
| Jun 15, 16 | ODONNELL FRANCIS E JR | CTO | Purchase | $192,000.00 | 2.56M | $491.52B | 16.56M |
| Jun 15, 16 | ODONNELL FRANCIS E JR | CTO | Sale | $192,000.00 | 2.56M | $491.52B | 11.44M |
| Jun 6, 16 | ODONNELL FRANCIS E JR | CTO | Sale | -- | 6.00M | -- | 14.00M |
| May 25, 16 | Mayne Pharma Group Ltd | 10 percent owner | Purchase | $47,924.00 | 27.89M | $1.34T | 149.06M |
| May 25, 16 | Mayne Pharma Group Ltd | 10 percent owner | Purchase | $0.01 | 28.36M | $340.37K | 71.95M |
| Aug 14, 14 | HedgePath, LLC | 10 percent owner | Purchase | -- | 82.16M | -- | 104.69M |
| Sep 10, 15 | HedgePath, LLC | 10 percent owner | Sale | $1,577,797.54 | 20.00M | $31.56T | 84.69M |
| Sep 10, 15 | ODONNELL FRANCIS E JR | CTO | Purchase | $1,577,797.54 | 20.00M | $31.56T | 20.00M |
| Aug 14, 15 | Cross Stefan | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Aug 14, 15 | Ono Richard Dana | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Aug 14, 15 | SEARS SAMUEL P JR | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Aug 14, 15 | Watson W. Mark | CTO | Purchase | -- | 400.00K | -- | 400.00K |
| May 15, 15 | Mayne Pharma Group Ltd | 10 percent owner | Purchase | $2,500,000.00 | 33.33M | $83.33T | 121.18M |
| May 15, 15 | Mayne Pharma Group Ltd | 10 percent owner | Purchase | $0.08 | 33.33M | $2.50M | 43.58M |
| Jul 18, 14 | Watson W. Mark | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Jul 18, 14 | Ono Richard Dana | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Jul 18, 14 | SEARS SAMUEL P JR | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Aug 6, 14 | Hasara Garrison J. | CFO | Purchase | -- | 3.50M | -- | 3.50M |
| Jul 18, 14 | VIRCA NICHOLAS J | CEO | Purchase | -- | 15.04M | -- | 15.04M |
| Jul 18, 14 | Cross Stefan | CTO | Purchase | -- | 300.00K | -- | 300.00K |
| Sep 8, 14 | Watson W. Mark | CTO | Purchase | $0.13 | 10.00K | $1.30K | 10.00K |
| Jun 24, 14 | HedgePath, LLC | 10 percent owner | Purchase | $0.08 | 20.00M | $1.50M | 22.53M |
| Jun 24, 14 | HedgePath, LLC | 10 percent owner | Purchase | $0.88 | 10.25M | $9.00M | 10.25M |
| Jun 24, 14 | HedgePath, LLC | 10 percent owner | Purchase | $639,767.00 | 2.53M | $1.62T | 2.53M |
| Jun 24, 14 | HedgePath, LLC | 10 percent owner | Purchase | -- | 71.64K | -- | 241.64K |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | $0.08 | 5.30M | $397.50K | 5.97M |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | $0.88 | 2.72M | $2.39M | 2.72M |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | $0.08 | 1.12M | $84.00K | 1.26M |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | $639,767.00 | 670.51K | $428.97B | 670.51K |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | $0.88 | 574.03K | $504.00K | 574.03K |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | $639,767.00 | 141.69K | $90.65B | 141.69K |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | -- | 18.98K | -- | 64.03K |
| Jun 24, 14 | ODONNELL FRANCIS E JR | CTO | Purchase | -- | 4.01K | -- | 13.53K |
| Jun 24, 14 | Ono Richard Dana | CTO | Sale | -- | -- | -- | -- |
| Jun 24, 14 | Watson W. Mark | CTO | Sale | -- | -- | -- | -- |
| Jun 24, 14 | Mayne Pharma Group Ltd | 10 percent owner | Sale | -- | 87.84M | -- | -- |
| Jun 24, 14 | Mayne Pharma Group Ltd | 10 percent owner | Sale | $0.09 | 10.25M | $900.00K | -- |
| Jun 24, 14 | Mayne Pharma Ventures Pty Ltd | CTO | Purchase | -- | 258.36K | -- | 258.36K |
| Jun 24, 14 | Mayne Pharma Ventures Pty Ltd | CTO | Purchase | $0.09 | 1 | $0.088 | 1 |
| Jun 24, 14 | Mayne Pharma Ventures Pty Ltd | CTO | Sale | -- | -- | -- | -- |
| Jun 24, 14 | Cross Stefan | CTO | Sale | -- | -- | -- | -- |
| Aug 12, 13 | VIRCA NICHOLAS J | CEO | Sale | -- | -- | -- | -- |
| Aug 12, 13 | Hasara Garrison J. | Officer | Sale | -- | -- | -- | -- |
| Aug 13, 13 | ODONNELL FRANCIS E JR | CTO | Purchase | -- | 45.05K | -- | 45.05K |
| Aug 13, 13 | ODONNELL FRANCIS E JR | CTO | Purchase | -- | 9.52K | -- | 9.52K |
| Aug 12, 13 | ODONNELL FRANCIS E JR | CTO | Sale | -- | -- | -- | -- |
| Aug 13, 13 | HedgePath, LLC | CTO | Purchase | -- | 170.00K | -- | 170.00K |
| Aug 12, 13 | HedgePath, LLC | CTO | Sale | -- | -- | -- | -- |
| Apr 12, 13 | FREER RICHARD J | CEO | Purchase | $0.05 | 2.85M | $130.09K | 7.49M |
| Apr 12, 13 | SEARS SAMUEL P JR | CTO | Purchase | $0.05 | 372.26K | $17.01K | 1.02M |
| Aug 22, 12 | FREER RICHARD J | CEO | Purchase | $0.02 | 2.02M | $40.50K | 4.64M |
| Jan 19, 10 | D'Sylva Paul | CTO | Sale | $0.50 | 19.10K | $9.55K | 271.22K |
| May 29, 09 | D'Sylva Paul | CTO | Purchase | $0.40 | 12.00K | $4.80K | 290.32K |
| May 15, 09 | D'Sylva Paul | CTO | Purchase | $0.38 | 510 | $193.8 | 278.32K |
| May 14, 09 | D'Sylva Paul | CTO | Purchase | $0.40 | 2.80K | $1.12K | 277.81K |
| May 5, 09 | D'Sylva Paul | CTO | Purchase | $0.35 | 23.93K | $8.38K | 275.01K |
| May 4, 09 | D'Sylva Paul | CTO | Purchase | $0.35 | 500 | $175 | 251.07K |
| May 1, 09 | D'Sylva Paul | CTO | Purchase | $0.35 | 5.87K | $2.04K | 250.57K |
| Apr 30, 09 | D'Sylva Paul | CTO | Purchase | $0.35 | 19.71K | $6.90K | 244.71K |
| Dec 29, 08 | REYNOLDS THOMAS R | Officer | Purchase | -- | 25.00K | -- | 50.72K |
| Dec 29, 08 | HARRIS ROBERT B | President | Purchase | -- | 25.00K | -- | 70.06K |
| Dec 29, 08 | FREER RICHARD J | COO | Purchase | -- | 25.00K | -- | 200.47K |
| Dec 29, 08 | BRENNAN JAMES H | Officer | Purchase | -- | 25.00K | -- | 34.87K |
| Sep 12, 08 | GUO WILLIAM X | CTO | Sale | -- | -- | -- | 2.61M |
| Sep 25, 08 | FREER RICHARD J | COO | Purchase | $0.98 | 5.00K | $4.90K | 180.88K |
| Sep 12, 08 | PharmAust Chemistry Ltd. | 10 percent owner | Sale | $1.45 | 2.15M | $3.12M | -- |
| Feb 9, 07 | PharmAust Chemistry Ltd. | 10 percent owner | Sale | -- | -- | -- | 2.15M |
| May 27, 08 | HARRIS ROBERT B | CTO | Sale | $1.59 | 10.00K | $15.85K | 45.06K |
| Apr 11, 08 | REYNOLDS THOMAS R | Officer | Sale | $2.89 | 4.00K | $11.56K | 29.52K |
Latest filing Checked hourly; insiders must file within 2 business days of a tradeAbout this data